Clinical Trials Directory

Trials / Unknown

UnknownNCT05486273

Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells

Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells : a Randomized Controlled Trial REBOND2-IPC 2022-009

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
108 (estimated)
Sponsor
Institut Paoli-Calmettes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To measure the impact of a coaching program on the patient's health-related quality of life 15 months post-transplant (M15/R12).

Detailed description

After signing the consent form and validating the inclusion and non-inclusion criteria, patients will be included in the study. They will be randomized unequally (2:1) into one of the study groups: * OC (Onco-Coaching) group: patients will undergo onco-coaching sessions at a rate of 1 session/month until 6 months post-inclusion (M9/R6). 73 patients will be randomized in this group * Group C (Control): Patients will not receive onco-coaching follow-up, but will be able to benefit from classical management in full autonomy. 35 patients will be randomized in this group

Conditions

Interventions

TypeNameDescription
OTHERinterviews with coachs, semi-structured interviews and questionnairesYou will be offered 6 coaching sessions at a rate of one session per month and the first interview will be conducted on the day of inclusion or within one month of inclusion, the others will take place at R6 and R12. Questionnaires will be administered on the day of inclusion and then at R1, R6, R9 and R12. RO is the day of inclusion and it corresponds to M3 (3 months post transplant)
OTHERsemi-structured interviews and questionnairesThe first interview will be conducted on the day of inclusion or within one month of inclusion, the others will take place at R6 and R12.Questionnaires will be administered on the day of inclusion and then at R1, R6, R9 and R12. RO is the day of inclusion and it corresponds to M3 (3 months post transplant)

Timeline

Start date
2023-01-02
Primary completion
2026-01-02
Completion
2026-01-02
First posted
2022-08-03
Last updated
2022-10-26

Source: ClinicalTrials.gov record NCT05486273. Inclusion in this directory is not an endorsement.